Pharmacoeconomic issues in the treatment of depression.

Keyphrases

• Acquisition Cost 33%
• Antidepressants 33%
• Clinical Practice Guidelines 33%
• Cost Advantage 33%
• Cost of Illness 33%
• Cost-effectiveness Analysis 66%
• Cost-effectiveness Study 33%
• Decision-making Practices 33%
• Depression Treatment 100%
• Disease Management 33%
• Dose Adjustment 33%
• Formulary Decisions 33%
• Healthcare Resource Utilization 33%
• Labor Costs 66%
• Laboratory Testing 33%
• Medical Surveillance 33%
• Overall Management 33%
• Pharmacoeconomics 100%
• Pharmacy 33%
• Selective Serotonin Reuptake Inhibitors 33%
• Treatment Side Effects 33%
• Treatment Strategy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidepressant 33%
• Disease 33%
• Effectiveness Study 33%
• Pharmacoeconomics 100%
• Selective Serotonin Reuptake Inhibitor 33%
• Side Effect 33%